PILOCARPINE |
OCUSERT PILO |
OCUSERT PILO-20 |
OCUSERT PILO-40 |
(3S,4R)-3-ETHYLDIHYDRO-4-((1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-2(3H)-FURANONE |
(3S-CIS)-3-ETHYLDIHYDRO-4-[(1-METHYL-1H-IMIDAZOL-5-YL)METHYL]-2(3H)-FURANONE |
SALAGEN® |
PILOCARPINE HYDROCHLORIDE |
PILOCARPINE NITRATE |
(+)-PILOCARPINE |
PILOKARPIN |
drugbank:01085 |
rxcui:8328 |
pubchem.compound:5910 |
chembl:CHEMBL550 |
chemidplus:92-13-7 |
Year of Approval | approved before 1982 |
Drug Class | miotics |
Drug Class | anti-glaucomic agents |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | for treatment of incontinence |
Drug Groups | investigational |
Drug Categories | antiglaucoma preparations and miotics |
Drug Categories | cholinergic receptor agonist |
Drug Categories | cytochrome p-450 cyp2a6 inhibitors (strong) |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | ophthalmologicals |
Drug Categories | parasympathomemetic (cholinergic) agents |
Drug Categories | sensory organs |
n/a |
agonist (activating) |
Direct Interaction? | False |
Endogenous Drug? | False |
Specific Action of the Ligand | Partial agonist |
agonist (activating) |
Novel drug target | Established target |
Trial Name | THVD-201 |
Specific Action of the Ligand | Partial agonist |
agonist (activating) |
Novel drug target | Established target |
Trial Name | THVD-201 |
Specific Action of the Ligand | Partial agonist |
partial agonist (activating) |
agonist (activating) |
Direct Interaction? | False |
Endogenous Drug? | False |
Specific Action of the Ligand | Partial agonist |
agonist (activating) |
Specific Action of the Ligand | Partial agonist |
Endogenous Drug? | False |
Direct Interaction? | False |
Pilocarpine 6% | Drug Brand |
92-13-7 | CAS Number |
ACAT SUK Kit (Accelerated COVID-19 Antibody Test Single Use Kit) | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
Drug Indications | for treatment of incontinence |
Drug Class | Small Molecule |
FDA Approval | approved |
Drug Class | anti-glaucomic agents |
Drug Class | miotics |
Year of Approval | approved before 1982 |
C748 | NCI drug code |
CHEMBL550 | ChEMBL Drug ID |
D06HLY | TTD Drug ID |